- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
June 1, 2022Chambers USA Recognizes Five Robins Kaplan Practice Groups And 17 Lawyers In 2022 Guide
-
June 1, 2022Seasoned Attorney Joins Firm’s Business Litigation Group
-
May 26, 2022Shira Shapiro Named Woman of Promise By The Pearl Society
-
June 3, 202219th Annual Advanced Insurance Law
-
June 9, 2022Building Your Brand: Perspectives and Insights from a Diverse Bar
-
June 10, 2022LGBTQ Legal Services: Transgender Name Change Clinic
-
May 24, 2022Briefly: Seeking Fees and Costs While on Appeal
-
May 19, 202211th Circ. Ban On Service Awards May Inhibit Class Actions
-
May 13, 2022Trademark Applications and the Murky Waters of Subject Matter Jurisdiction
-
June 2, 2022Sandberg Stepping Down as Meta COO After 14 Years
-
June 1, 2022Markets Revert to Recent Form as Pessimism Takes Hold
-
May 27, 2022Unexpectedly Strong Retail Sales Pull Markets Back from the Brink
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Generic Launches
Reference Listed Drug, NDA Holder, Generic Drug Name, ANDA Applicant(s), Indication and Launch Date
Spring 2014
| Reference Listed Drug | NDA Holder | Generic Drug Name | ANDA Applicant(s) |
Indication | Launch Date |
|---|---|---|---|---|---|
|
Detrol LA |
Pfizer |
Tolterodine Tartrate Extended-Release Capsules |
Teva |
Treatment of overactive bladder with symptoms of urinary frequency, urgency, and incontinence |
1/3/2014
|
|
Esomeprazole Strontium |
Amneal |
Esomeprazole Strontium Delayed-Release Capsules |
Amneal Pharms |
Gastroesophageal reflux disease (GERD) |
1/6/2014 |
|
Detrol LA |
Pfizer |
Tolterodine Tartrate Extended-Release Capsules |
Mylan |
Treatment of overactive bladder with symptoms of urinary frequency, urgency, and incontinence |
1/7/2014 |
|
Micardis |
Boehringer Ingelheim |
Telmisartan Immediate-Release Tablets |
Actavis |
Hypertension |
1/8/2014 |
|
Micardis |
Boehringer Ingelheim |
Telmisartan Immediate-Release Tablets |
Roxane Labs |
Hypertension |
1/8/2014 |
|
Myfortic |
Novartis |
Mycophenolic Acid Delayed-Release Tablets |
Mylan |
Prophylaxis of organ rejection in adult patients receiving a kidney transplant and for the prophylaxis of organ rejection in pediatric patients 5 years of age and older who are at least 6 months post kidney transplant |
1/9/2014 |
|
Vanos |
Medicis |
Fluocinonide Cream 0.1% |
Perrigo |
Relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in patients 12 years of ago or older |
1/14/2014 |
|
Lanoxin |
Covis Pharma |
Digoxin Tablets |
Par Pharms |
Treatment of mild to moderate heart failure in adults, increasing myocardial contractility in pediatric patients with heart failure; and control of resting ventricular rate in patients with chronic atrial fibrillation in adults |
1/16/2014 |
|
Prandin |
Novo Nordisk |
Repaglinide Tablets |
Mylan |
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus |
1/23/2014 |
|
Prandin |
Novo Nordisk |
Repaglinide Tablets |
Perrigo |
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus |
1/24/2014 |
|
Hectorol |
Genzyme |
Doxercalciferol Injection Vials |
Sandoz |
Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis |
2/5/2014 |
|
Hectorol |
Genzyme |
Doxercalciferol Capsules |
Roxane Labs |
Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis |
2/18/2014 |
|
Imitrex STATdose Pen |
Glaxo Group Limited |
Sumatriptan Injection USP, Autoinjector System 6 |
Dr. Reddy's Labs |
Migraine headaches with or without aura |
2/25/2014 |
|
Micardis |
Boehringer Ingelheim |
Telmisartan / Hydrochlorothiazide Tablets |
Roxane Labs |
Hypertension |
2/28/2014 |
|
Evista |
Eli Lilly |
Raloxifene Tablets |
Teva |
Treat or prevent osteoporosis in postmenopausal women |
3/4/2014 |
|
Avelox |
Bayer / Merck Sharp & Dohme Corp. |
Moxifloxacin Hydrochloride Tablets |
Dr. Reddy's Labs |
Bacterial infections of theskin, sinuses, lungs, or stomach |
3/5/2014 |
|
Xeloda |
Genentech |
Capecitabine Tablets |
Teva |
Treatment of breast cancer and colon or rectum cancer that has spread to other parts of the body |
3/7/2014 |
|
Naloxone Hydrochloride Injection |
Hospira |
Naloxone Hydrochloride Injection |
Mylan |
Indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including propoxyphene, methadone, and certain mixed agonist-antagonist analgesics |
3/11/2014 |
|
Hectorol |
Genzyme |
Doxercalciferol Capsules |
Prasco Laboratories |
Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis |
3/11/2014 |
|
Neptazane |
Lederle |
Methazolamide Tablets |
Perrigo |
Treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, such as chronic open-angle glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where lowering the intraocular pressure is desired before surgery |
3/12/2014 |
|
Niaspan |
AbbVie |
Niacin Extended-Release Tablets |
Lupin |
Reduce elevated TC, LDL-C, Apo B and TG levels, and to increase HDL-C in patients with primary hyperlipidemia and mixed dyslipidemia |
3/21/2014 |
|
Caduet |
Pfizer |
Amlodipine Besylate / Atorvastatin Calcium Tablets |
Dr. Reddy's Labs |
Hypertension or Angina |
3/27/2014 |
|
Prevpac |
Takeda |
lansoprazole Capsules / Amoxicillin Capsules / Clarithromycin Tablets |
Sandoz |
Eradication of H. pylori infection in patients with duodenal ulcer disease |
3/27/2014 |
Related Professionals
Related Publications
Related News
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.